Aung FootHealth Clinics & Advanced Wound Care Center Enrolling Patients With Chronic Diabetic Foot Ulcers For Matrix Clinical Trial
The MATRIX (A Phase 2b Study of GAM501 in the Treatment of Diabetic Ulcers in the Lower Extremities) trial is a randomized, double-blind, placebo-controlled, comparator arm (standard of care) safety and efficacy study to evaluate GAM501 (Ad5PDGF-B/bovine type I collagen gel) that is topically administered once or twice over the course of the study. The primary endpoint will be the effect of Excellarate on the incidence of complete ulcer closure at 12 weeks or earlier.
"The Excellarate topical gel using Gene Activated Matrix (GAM) technology is designed to provide localized and sustained cellular release of platelet-derived growth factor-BB protein (PDGF-BB). Sustained delivery of PDGF-BB directly at the wound site is believed to stimulate angiogenesis and granulation tissue formation through the recruitment and proliferation of chemotactic cells such as monocytes, fibroblasts, and endothelial cells, which are necessary for the stimulation of a variety of wound healing processes," stated Barbara J. Aung, DPM, CWS Aung FootHealth Clinics & Advanced Wound Care Center, and a trial investigator.
There are currently more than 20 million Americans who have diabetes and this number is expected to double by the year 2030. Many diabetic patients suffer from peripheral neuropathy, or a loss of feeling in their feet, that puts them at increased risk of foot ulceration. Over 850,000 chronic diabetic ulcers are diagnosed in the U.S. each year. Patients with non-healing ulcers are more susceptible to infections that may lead to amputation of the affected foot or leg.
Aung FootHealth Clinics & Advanced Wound Care Center is among an estimated 25 sites participating in the MATRIX trial. The trial is expected to enroll 210 patients nationwide.
For over 15 years Barbara J. Aung, DPM, CWS and Aung FootHealth Clinics & Advanced Wound Care Center has been a leader in the field of Podiatric Medicine specializing in Advanced Wound Care, Limb Preservation and Amputation Prevention. Most chronic/long standing wounds that are treated in our wound care center heal within 8-12 weeks. In fact, over 95% of the wounds that are treated heal fully. Using proven clinical pathways, our specifically trained staff provides comprehensive individualized treatment to patients.
Please visit our website at http://www.healthy-feet.com for additional information on "Keeping your Feet Healthy for the Journeys...Yet to be Made."
Aung FootHealth Clinics & Advanced Wound Care Center
http://www.healthy-feet.com
Aung FootHealth & Clinici avansat centru de îngrijire a plãgilor, unde se pregãtesc pacienþii cu ulcere cronice piciorului diabetic pentru matrice studiu clinic - Aung FootHealth Clinics & Advanced Wound Care Center Enrolling Patients With Chronic Diabetic Foot Ulcers For Matrix Clinical Trial - articole medicale engleza - startsanatate